Physician profile
Gregory S Windham
NPI 1154362275
$729.29
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $105 · 2021: $52.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $125.00 | 2019 | |
| Ethicon US, LLC | $119.00 | 2019 | |
| Intuitive Surgical, INC. | $98.89 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $77.99 | 2019-2021 | |
| Integra Lifesciences Corporation | $69.73 | 2019-2020 | |
| Melinta Therapeutics, LLC | $46.76 | 2019-2020 | |
| Smith+Nephew, INC. | $44.68 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $23.00 | 2020 | |
| Davol INC. | $22.42 | 2019 | |
| Convatec INC. | $20.19 | 2019 | |
| Acera Surgical, INC. | $20.10 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.01 | 2019 | |
| Allergan, INC. | $14.93 | 2019 | |
| Covidien Lp | $14.68 | 2020 | |
| Merck Sharp & Dohme LLC | $13.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Windham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.